11:05 pm - Wednesday February 22, 2012

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011

Buy This Report Now

Call US : USA-CANADA Toll Free: +1-866-997-948 or +1-518-618-1030

Email: sales@twease.org
Request Sample on This Report

Your Name (required)

Your Email (required)

Your Phone (required)

Report Name (required)

Subject

Your Message

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011

Diabetes Devices Market

DescriptionType 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011

Summary

GlobalData’s clinical trial report, Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011″ provides data on the Type 1 Diabetes (Juvenile Diabetes) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 1 Diabetes (Juvenile Diabetes). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Type 1 Diabetes (Juvenile Diabetes) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Type 1 Diabetes (Juvenile Diabetes) 25
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Novo Nordisk A/S 37
Clinical Trial Overview of Novo Nordisk A/S 37
Sanofi 42
Clinical Trial Overview of Sanofi 42
Eli Lilly and Company 45
Clinical Trial Overview of Eli Lilly and Company 45
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Amylin Pharmaceuticals, Inc. 49
Clinical Trial Overview of Amylin Pharmaceuticals, Inc. 49
MannKind Corporation 51
Clinical Trial Overview of MannKind Corporation 51
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
Wockhardt Limited 53
Clinical Trial Overview of Wockhardt Limited 53
Biodel Inc. 54
Clinical Trial Overview of Biodel Inc. 54
Halozyme Therapeutics, Inc. 55
Clinical Trial Overview of Halozyme Therapeutics, Inc. 55
Becton, Dickinson and Company 56
Clinical Trial Overview of Becton, Dickinson and Company 56
AstraZeneca PLC 57
Clinical Trial Overview of AstraZeneca PLC 57
Diamyd Medical AB 58
Clinical Trial Overview of Diamyd Medical AB 58
MacroGenics, Inc. 59
Clinical Trial Overview of MacroGenics, Inc. 59
Sangamo BioSciences, Inc. 60
Clinical Trial Overview of Sangamo BioSciences, Inc. 60
DexCom, Inc. 61
Clinical Trial Overview of DexCom, Inc. 61
Biocon Limited 62
Clinical Trial Overview of Biocon Limited 62
Medtronic Diabetes 63
Clinical Trial Overview of Medtronic Diabetes 63
Hypo-Safe A/S 64
Clinical Trial Overview of Hypo-Safe A/S 64
Andromeda Biotech Ltd. 65
Clinical Trial Overview of Andromeda Biotech Ltd. 65
Clinical Trial Overview of Top Universities / Institutes / Hospitals 66
The National Institute of Diabetes and Digestive and Kidney Diseases 66
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 66
The National Institute of Allergy and Infectious Diseases 68
Clinical Trial Overview of the National Institute of Allergy and Infectious Diseases 68
Rabin Medical Center 69
Clinical Trial Overview of Rabin Medical Center 69
Baylor College of Medicine 70
Clinical Trial Overview of Baylor College of Medicine 70
Vanderbilt University 71
Clinical Trial Overview of Vanderbilt University 71
University of Colorado 72
Clinical Trial Overview of University of Colorado 72
University of Virginia 73
Clinical Trial Overview of University of Virginia 73
Yale University 74
Clinical Trial Overview of Yale University 74
Steno Diabetes Center A/S 75
Clinical Trial Overview of Steno Diabetes Center A/S 75
University of Minnesota 76
Clinical Trial Overview of University of Minnesota 76
University Hospital, Grenoble 77
Clinical Trial Overview of University Hospital, Grenoble 77
The Medical University of Graz 78
Clinical Trial Overview of The Medical University of Graz 78
Park Nicollet Institute 79
Clinical Trial Overview of Park Nicollet Institute 79
Assistance Publique – Hopitaux de Paris 80
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 80
Emory University 81
Clinical Trial Overview of Emory University 81
University of Cambridge 82
Clinical Trial Overview of University of Cambridge 82
University of Alberta 83
Clinical Trial Overview of University of Alberta 83
Nemours Children’s Clinic 84
Clinical Trial Overview of Nemours Children’s Clinic 84
The University of Texas Southwestern Medical Center at Dallas 85
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 85
The Children’s Mercy Hospital 86
Clinical Trial Overview of The Children’s Mercy Hospital 86
Five Key Clinical Profiles 87
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 108
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109

List of Table:List of Tables
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Zone, 2011* 9
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 12
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 13
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries, 2011* 14
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 15
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 16
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, BRIC Countries, 2011* 17
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, G7 Countries, 2011* 18
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, E7 Countries, 2011* 20
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Phase, 2011* 22
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 23
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Suspended Clinical Trials, 2011* 25
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 26
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Terminated Clinical Trials, 2011* 27
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 33
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 35
Type 1 Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 36
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2011* 37
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011* 42
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 45
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 47
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amylin Pharmaceuticals, Inc., 2011* 49
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2011* 51
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 52
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wockhardt Limited, 2011* 53
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biodel Inc., 2011* 54
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Halozyme Therapeutics, Inc., 2011* 55
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Becton, Dickinson and Company, 2011* 56
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 57
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Diamyd Medical AB, 2011* 58
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2011* 59
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangamo BioSciences, Inc., 2011* 60
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by DexCom, Inc., 2011* 61
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocon Limited, 2011* 62
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Diabetes, 2011* 63
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hypo-Safe A/S, 2011* 64
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Andromeda Biotech Ltd., 2011* 65
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 66
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011* 68
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2011* 69
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011* 70
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011* 71
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011* 72
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2011* 73
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011* 74
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2011* 75
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2011* 76
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2011* 77
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2011* 78
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Park Nicollet Institute, 2011* 79
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2011* 80
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2011* 81
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2011* 82
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2011* 83
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nemours Children’s Clinic, 2011* 84
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2011* 85
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children’s Mercy Hospital, 2011* 86

List of Charts:List of Figures
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 9
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 15
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, G7 Countries (%), 2011* 18
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, E7 Countries (%), 2011* 20
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 22
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 23
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 32
Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 34
Type 1 Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 36
GlobalData Methodology 107

Related posts:

  1. Global Diabetes Devices Market & Diabetes Drugs Market (2011- 2016)

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011

Buy This Report Now

Call US : USA-CANADA Toll Free: +1-866-997-948 or +1-518-618-1030

Email: sales@twease.org
Request Sample on This Report

Your Name (required)

Your Email (required)

Your Phone (required)

Report Name (required)

Subject

Your Message

Filed in: GlobalData, Pharmaceuticals
China Market Research